» Articles » PMID: 35080425

Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay Within a Single Infected CD4 T Cell

Overview
Journal J Virol
Date 2022 Jan 26
PMID 35080425
Authors
Affiliations
Soon will be listed here.
Abstract

The HIV-1 Nef and Vpu accessory proteins are known to protect infected cells from antibody-dependent cellular cytotoxicity (ADCC) responses by limiting exposure of CD4-induced (CD4i) envelope (Env) epitopes at the cell surface. Although both proteins target the host receptor CD4 for degradation, the extent of their functional redundancy is unknown. Here, we developed an intracellular staining technique that permits the intracellular detection of both Nef and Vpu in primary CD4 T cells by flow cytometry. Using this method, we show that the combined expression of Nef and Vpu predicts the susceptibility of HIV-1-infected primary CD4 T cells to ADCC by HIV+ plasma. We also show that Vpu cannot compensate for the absence of Nef, thus providing an explanation for why some infectious molecular clones that carry a LucR reporter gene upstream of Nef render infected cells more susceptible to ADCC responses. Our method thus represents a new tool to dissect the biological activity of Nef and Vpu in the context of other host and viral proteins within single infected CD4 T cells. HIV-1 Nef and Vpu exert several biological functions that are important for viral immune evasion, release, and replication. Here, we developed a new method allowing simultaneous detection of these accessory proteins in their native form together with some of their cellular substrates. This allowed us to show that Vpu cannot compensate for the lack of a functional Nef, which has implications for studies that use Nef-defective viruses to study ADCC responses.

Citing Articles

CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies.

Richard J, Sannier G, Zhu L, Prevost J, Marchitto L, Benlarbi M mBio. 2024; 15(11):e0182724.

PMID: 39373535 PMC: 11559134. DOI: 10.1128/mbio.01827-24.


Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity.

Marchitto L, Benlarbi M, Prevost J, Laumaea A, Descoteaux-Dinelle J, Medjahed H mBio. 2023; 14(4):e0078923.

PMID: 37404017 PMC: 10470595. DOI: 10.1128/mbio.00789-23.


Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.

Pickering S, Sumner J, Kerridge C, Perera M, Neil S mBio. 2023; 14(4):e0329322.

PMID: 37341489 PMC: 10470808. DOI: 10.1128/mbio.03293-22.


Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity.

Laumaea A, Marchitto L, Ding S, Beaudoin-Bussieres G, Prevost J, Gasser R Cell Rep. 2023; 42(1):111983.

PMID: 36640355 PMC: 9941794. DOI: 10.1016/j.celrep.2022.111983.


HIV-1 Vpu restricts Fc-mediated effector functions in vivo.

Prevost J, Anand S, Rajashekar J, Zhu L, Richard J, Goyette G Cell Rep. 2022; 41(6):111624.

PMID: 36351384 PMC: 9703018. DOI: 10.1016/j.celrep.2022.111624.


References
1.
Mitchell J, Pollara J, Dietze K, Edwards R, Nohara J, Nguessan K . Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection. J Clin Invest. 2021; 132(1). PMC: 8718150. DOI: 10.1172/JCI150937. View

2.
Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, Cheng Y . HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2009; 11(1):110-22. PMC: 2796297. DOI: 10.1111/j.1600-0854.2009.01006.x. View

3.
Richard J, Prevost J, Alsahafi N, Ding S, Finzi A . Impact of HIV-1 Envelope Conformation on ADCC Responses. Trends Microbiol. 2017; 26(4):253-265. DOI: 10.1016/j.tim.2017.10.007. View

4.
Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard J . Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med. 1996; 2(3):338-42. DOI: 10.1038/nm0396-338. View

5.
Fenton-May A, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman M . Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology. 2013; 10:146. PMC: 3907080. DOI: 10.1186/1742-4690-10-146. View